JP2017530092A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017530092A5 JP2017530092A5 JP2017504375A JP2017504375A JP2017530092A5 JP 2017530092 A5 JP2017530092 A5 JP 2017530092A5 JP 2017504375 A JP2017504375 A JP 2017504375A JP 2017504375 A JP2017504375 A JP 2017504375A JP 2017530092 A5 JP2017530092 A5 JP 2017530092A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- molecule
- antibody molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 14
- 239000002260 anti-inflammatory agent Substances 0.000 claims 6
- 230000003115 biocidal effect Effects 0.000 claims 6
- 231100000433 cytotoxic Toxicity 0.000 claims 6
- 230000001472 cytotoxic effect Effects 0.000 claims 6
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 5
- 108010047041 Complementarity Determining Regions Proteins 0.000 claims 4
- 230000002285 radioactive effect Effects 0.000 claims 3
- 102000008186 Collagen Human genes 0.000 claims 2
- 108010035532 Collagen Proteins 0.000 claims 2
- 102000004127 Cytokines Human genes 0.000 claims 2
- 108090000695 Cytokines Proteins 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 229920001436 collagen Polymers 0.000 claims 2
- 201000008482 osteoarthritis Diseases 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 229940124599 anti-inflammatory drug Drugs 0.000 claims 1
- 230000003110 anti-inflammatory effect Effects 0.000 claims 1
- 108020001507 fusion proteins Proteins 0.000 claims 1
- 102000037865 fusion proteins Human genes 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1413357.3A GB201413357D0 (en) | 2014-07-28 | 2014-07-28 | Antibodies for treatment and diagnosis |
| GB1413357.3 | 2014-07-28 | ||
| PCT/EP2015/067314 WO2016016269A1 (en) | 2014-07-28 | 2015-07-28 | Anti-collagen antibodies for treatment and diagnosis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017530092A JP2017530092A (ja) | 2017-10-12 |
| JP2017530092A5 true JP2017530092A5 (enExample) | 2019-04-18 |
| JP6577016B2 JP6577016B2 (ja) | 2019-09-18 |
Family
ID=51587356
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017504375A Expired - Fee Related JP6577016B2 (ja) | 2014-07-28 | 2015-07-28 | 治療及び診断のための抗コラーゲン抗体 |
| JP2017504376A Pending JP2017526654A (ja) | 2014-07-28 | 2015-07-28 | 治療及び診断のための抗体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017504376A Pending JP2017526654A (ja) | 2014-07-28 | 2015-07-28 | 治療及び診断のための抗体 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US10098976B2 (enExample) |
| EP (2) | EP3174900A1 (enExample) |
| JP (2) | JP6577016B2 (enExample) |
| CA (1) | CA2992136C (enExample) |
| GB (1) | GB201413357D0 (enExample) |
| WO (2) | WO2016016269A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3039316A1 (en) | 2016-11-28 | 2018-05-31 | Chugai Seiyaku Kabushiki Kaisha | Ligand-binding molecule having adjustable ligand binding activity |
| CN110177875B (zh) | 2016-11-28 | 2023-11-28 | 中外制药株式会社 | 包含抗原结合结构域和运送部分的多肽 |
| EP3555125A4 (en) * | 2016-12-15 | 2019-11-20 | The Brigham and Women's Hospital, Inc. | TISSUE-BASED BIOLOGICS FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES |
| GB201621806D0 (en) | 2016-12-21 | 2017-02-01 | Philogen Spa | Immunocytokines with progressive activation mechanism |
| AU2018226215B2 (en) * | 2017-02-24 | 2019-11-21 | Philogen S.P.A. | Immunoconjugates with optimized linkers and orientation |
| WO2019094938A2 (en) | 2017-11-13 | 2019-05-16 | The University Of Chicago | Methods and compositions for the treatment of wounds |
| BR112020010450A2 (pt) | 2017-11-28 | 2020-11-24 | Chugai Seiyaku Kabushiki Kaisha | polipeptídeo que inclui domínio de ligação a antígeno e seção transportadora |
| WO2019107384A1 (ja) | 2017-11-28 | 2019-06-06 | 中外製薬株式会社 | リガンド結合活性が調整可能なリガンド結合分子 |
| WO2019183131A1 (en) | 2018-03-19 | 2019-09-26 | Bioventures, Llc | Periostin antibodies and methods of using the same |
| JP7474702B2 (ja) | 2018-03-28 | 2024-04-25 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | エキソソームから単離されたｄｎａにおけるエピジェネティック変化の同定法 |
| US12077577B2 (en) | 2018-05-30 | 2024-09-03 | Chugai Seiyaku Kabushiki Kaisha | Polypeptide comprising aggrecan binding domain and carrying moiety |
| US12060422B2 (en) * | 2018-06-29 | 2024-08-13 | Alector Llc | Anti-SIRP-Beta1 antibodies and methods of use thereof |
| US20230139944A1 (en) * | 2019-06-21 | 2023-05-04 | Board Of Regents, The University Of Texas System | Targeting alpha3beta1 integrin for treatment of cancer and other diseases |
| CA3148291A1 (en) * | 2019-09-11 | 2021-03-18 | Boehringer Ingelheim Io Canada, Inc. | Methods of treating cancer by the use of pd-1 axis inhibitors and anti-periostin antibodies |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5541295A (en) | 1993-02-12 | 1996-07-30 | The Board Of Governors For Higher Education State Of Rhode Island And Providence Plantations | Detection of type II collagen and its peptides |
| CA2358517C (en) * | 1999-01-06 | 2012-10-09 | University Of Southern California | Method and composition for angiogenesis inhibition |
| WO2003019136A2 (en) * | 2001-08-06 | 2003-03-06 | The Regents Of The University Of California | Methods for inhibiting angiogenesis |
| GB0207224D0 (en) * | 2002-03-27 | 2002-05-08 | Novartis Forschungsstiftung | Tenascin-W compositions and uses thereof |
| GB0708585D0 (en) | 2007-05-03 | 2007-06-13 | Queen Mary & Westfield College | Novel antibody and use in diagnosis and therapy of arthropathies |
| KR20120064072A (ko) | 2009-09-16 | 2012-06-18 | 시오노기세야쿠 가부시키가이샤 | 콜라겐 네오에피토프 항체 |
| EP2621950A4 (en) * | 2010-09-27 | 2015-09-02 | Janssen Biotech Inc | ANTIBODIES FOR BINDING HUMAN COLLAGEN II |
-
2014
- 2014-07-28 GB GBGB1413357.3A patent/GB201413357D0/en not_active Ceased
-
2015
- 2015-07-28 WO PCT/EP2015/067314 patent/WO2016016269A1/en not_active Ceased
- 2015-07-28 JP JP2017504375A patent/JP6577016B2/ja not_active Expired - Fee Related
- 2015-07-28 US US15/329,223 patent/US10098976B2/en not_active Expired - Fee Related
- 2015-07-28 US US15/329,222 patent/US10125190B2/en not_active Expired - Fee Related
- 2015-07-28 CA CA2992136A patent/CA2992136C/en not_active Expired - Fee Related
- 2015-07-28 JP JP2017504376A patent/JP2017526654A/ja active Pending
- 2015-07-28 EP EP15744198.1A patent/EP3174900A1/en not_active Withdrawn
- 2015-07-28 EP EP15744195.7A patent/EP3174899A1/en not_active Withdrawn
- 2015-07-28 WO PCT/EP2015/067309 patent/WO2016016265A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017530092A5 (enExample) | ||
| JP2013121353A5 (enExample) | ||
| HRP20201975T1 (hr) | Neutralizirajuća protutijela anti-influenca a virusa i njihova uporaba | |
| HRP20200882T1 (hr) | Vezujuće molekule specifične za asct2 i njihova uporaba | |
| FI3487882T3 (fi) | Gprc5d-vasta-aineita, bispesifisiä antigeeniä sitovia molekyylejä, jotka sitovat gprc5d:tä ja cd3:a, sekä niiden käyttötapoja | |
| JP2010534237A5 (enExample) | ||
| NZ602040A (en) | Anti-lrp6 antibodies | |
| JP2010523541A5 (enExample) | ||
| JP2011502137A5 (enExample) | ||
| HRP20180352T1 (hr) | Protutijela anti-fcrh5 | |
| HRP20201022T1 (hr) | Potpuno ljudsko antitijelo protiv ljudskog cd137 i njegova uporaba | |
| HRP20191678T1 (hr) | Pd-1 protutijelo, njegov fragment koji se veže na antigen, i njegova medicinska primjena | |
| HRP20231578T1 (hr) | Molekule protutijela na april i njihove uporabe | |
| EA201401134A1 (ru) | Hla-рестиктированные пептидоспецифические антигенсвязывающие белки | |
| HRP20201064T1 (hr) | Postupci liječenja tauopatije | |
| HRP20221088T1 (hr) | Protutijela i postupci uporabe | |
| PE20150025A1 (es) | Anticuerpos e inmunoconjugados contra ly6e y metodos de uso | |
| JP2017535257A5 (enExample) | ||
| HRP20211444T1 (hr) | Anti-dll3 antitijelo | |
| JP2016135783A5 (enExample) | ||
| HRP20180015T1 (hr) | Anti-mezotelinski imunokonjugati i njihova uporaba | |
| HRP20120701T1 (hr) | Humana monoklonska protutijela protiv fukozil-gm1 i postupci za uporabu antifukozil-gm1 | |
| PE20150211A1 (es) | Anticuerpos e inmunoconjugados anti-cd79b | |
| JP2012010714A5 (enExample) | ||
| RU2017114968A (ru) | Связывающие молекулы, а именно антитела, способные связываться с l1cam (cd171) |